Simplex Trading’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,089
| Closed | -$191K | – | 10633 |
|
|
2022
Q4 | $191K | Sell |
7,089
-7,022
| -50% | -$185K | ﹤0.01% | 4282 |
|
|
2022
Q3 | $253K | Buy |
+14,111
| New | +$225K | ﹤0.01% | 4306 |
|
|
2022
Q2 | – | Sell |
-4,510
| Closed | -$49.8K | – | 11562 |
|
|
2022
Q1 | $60K | Sell |
4,510
-5,227
| -54% | -$70.1K | ﹤0.01% | 6897 |
|
|
2021
Q4 | $151K | Sell |
9,737
-1,435
| -13% | -$27.4K | ﹤0.01% | 5597 |
|
|
2021
Q3 | $254K | Sell |
11,172
-95
| -0.8% | -$2.09K | ﹤0.01% | 5209 |
|
|
2021
Q2 | $256K | Buy |
11,267
+442
| +4% | +$9.3K | ﹤0.01% | 5263 |
|
|
2021
Q1 | $222K | Buy |
+10,825
| New | +$246K | ﹤0.01% | 4599 |
|
|
2020
Q4 | – | Sell |
-45,934
| Closed | -$894K | – | 9323 |
|
|
2020
Q3 | $645K | Buy |
45,934
+31,871
| +227% | +$593K | ﹤0.01% | 2727 |
|
|
2020
Q2 | $289K | Buy |
14,063
+12,952
| +1,166% | +$176K | ﹤0.01% | 3572 |
|
|
2020
Q1 | $8K | Sell |
1,111
-2,324
| -68% | -$26.1K | ﹤0.01% | 6634 |
|
|
2019
Q4 | $53K | Buy |
3,435
+3,335
| +3,335% | +$33.6K | ﹤0.01% | 5136 |
|
|
2019
Q3 | $0 | Buy |
+100
| New | +$742 | ﹤0.01% | 8094 |
|
Other funds holding MYOV
Simplex Trading's MYOV Position: Q1 2023 in Review
Simplex Trading sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 7,089 shares — an estimated $191K sold.
Simplex Trading first reported a position in MYOV in Q3 2019 and held it in 12 quarters. The position peaked at $645K in Q3 2020. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- Simplex Trading reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- Simplex Trading sold 7,089 Myovant Sciences Ltd. shares in Q1 2023, an estimated $191K.
- Simplex Trading first reported a position in Myovant Sciences Ltd. in Q3 2019 and held it in 12 quarters.
- Simplex Trading's Myovant Sciences Ltd. position peaked at $645K in Q3 2020.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.